Drug Patent Expirations for Feb 20 2013

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
body { font-family:Calibri, tahoma, arial,
sans-serif;}table { font-size:12px; font-family:Calibri, tahoma, arial,
sans-serif; border-collapse:collapse; margin: 0px auto;}.xsnazzy h1,
.zsnazzy h1 { margin:0; font-size:1.2em; padding:0 10px 5px 10px;
border-bottom:1px solid #444; }.xsnazzy { background: transparent; margin:0
3px;}.xtop, .xbottom { display:block; background:transparent;
font-size:1px; }.xb1, .xb2, .xb3, .xb4 { display:block; overflow:hidden;
}.xb1, .xb2, .xb3 { height:1px; }.xb2, .xb3, .xb4 { background:#fff;
border-left:1px solid #444; border-right:1px solid #444; }.xb1 { margin:0
5px; background:#444; }.xb2 { margin:0 3px; border-width:0 2px; }.xb3 {
margin:0 2px; }.xb4 { height:2px; margin:0 1px;}.xboxcontent {
display:block; border:0 solid #444; border-width:0 1px; height:auto; }*
html .xboxcontent { height:1px; } td { padding:3px; } tr { border:.5pt;
background-color:#FFF; }


This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Drug Patent Expirations for February 20 2013

Tradename Applicant Generic Name Patent
ARRANON Smithkline Beecham nelarabine Feb 20, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.


selling drugs

What are the Top-selling

infographics &raquo

DrugPatentWatch Serves Your Competitive Intelligence

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
  • More…
See the Database
and Plan
. Contact Us with any

The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or

Click here for reuse options!
Copyright 2013 Biotechblog

Like this:

Comments are closed.

%d bloggers like this: